Fabrication of doxorubicin conjugated methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) nanoparticles and study on their in vitro antitumor activities

References

• Florea AM, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers. 2011;3(1):1351–1371.
   PubMedGoogle Scholar
• Zheng J. Advance of the targeted anti-tumor drugs with small molecule compounds. J Int Oncol. 2012;39(3):172–175.
   Google Scholar
• Hamilton G, Rath B, Klameth L, et al. Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoence. 2015;2(7):629–634.
   Google Scholar
• Barrett JS, Gupta M, Mondick JT. Model-based drug development applied to oncology. Expert Opin Drug Discov. 2007;2(2):185–209.
   PubMed Web of Science ®Google Scholar
• Kumar S, Hui L. In silico design of anticancer peptides. Methods Mol Biol. 2017;1647:245–254.
   PubMedGoogle Scholar
• Ernsting MJ, Murakami M, Roy A, et al. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Controlled Release. 2013;172(3):782–794.
   PubMed Web of Science ®Google Scholar
• Lazzaroni M, Porro GB. Gastrointestinal side‐effects of traditional non‐steroidal anti‐inflammatory drugs and new formulations. Aliment Pharmacol Ther. 2004;20:48–58.
   PubMed Web of Science ®Google Scholar
• Hoste K, Winne KD, Schacht E. Polymeric prodrugs. Int J Pharm. 2004;277(1–2):119–131.
   PubMedGoogle Scholar
• Tatsuro O, Yuichi O. Macromolecular prodrugs. Prog Polym Sci. 1995;20(2):211–257.
   Web of Science ®Google Scholar
• Beauchamp LM, Orr GF, Miranda PD, et al. Amino acid ester prodrugs of acyclovir. Antivir Chem Chemother. 1992; 3:157–164.
   Web of Science ®Google Scholar
• Leonard JK, Turek D, Sloan KB, et al. Polyethylene prodrugs using precisely placed pharmaceutical agents. Macromol Chem Phys. 2010;211(2):154–165.
   Web of Science ®Google Scholar
• Prokai L, Prokai K. Prodrugs for use as ophthalmic agents. 2008.
   Google Scholar
• Ravagnan G, Falchetti R, Lanzilli G, et al. Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field. In Particular as substances with immunomodulating activity. 2008.
   Google Scholar
• Greenwald RB, Choe YH. Polymer conjugates of biologically active agents and extension moieties for facilitating conjugation of biologically active agents to polymeric terminal groups. 2001.
   Google Scholar
• Zuluaga MF, Gabriel D, Lange N. Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs. Mol Pharm. 2012;9(6):1570–1579.
   PubMedGoogle Scholar
• Abbadessa A, Stefano AD, Sozio P, et al. Designing prodrugs for the treatment of Parkinson's disease. Expert Opin Drug Discov. 2012;7(5):385–406.
   PubMed Web of Science ®Google Scholar
• D'Souza AJM, Topp EM. Release from polymeric prodrugs: linkages and their degradation. J Pharm Sci. 2010;93(8):1962–1979.
   Google Scholar
• Qiao J, Jiang J, Liu L, et al. Enzyme reactor based on reversible pH-controlled catalytic polymer porous membrane. Acs Appl Mater Interfaces. 2019;11(16):15133–15140.
   PubMed Web of Science ®Google Scholar
• Ning LI, Zhang H, Liu XY, et al. Advances in pH-responsive polymeric prodrugs. Chin J New Drugs Clin Remedies. 2015;34(08):578–584. (In Chinese).
   Google Scholar
• Andrgie AT, Birhan YS, Mekonnen TW, et al. Redox-responsive heparin-chlorambucil conjugate polymeric prodrug for improved anti-tumor activity. Polymers. 2019;12(1):43.
   Web of Science ®Google Scholar
• Rutz M, Metzger J, Gellert T, et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol. 2004;34(9):2541–2550.
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Mori T, Katayama Y, et al. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing rats. J Control Release. 2009;139(1):81–84.
   PubMed Web of Science ®Google Scholar
• Webster R, Elliott V, Park BK, et al. PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals: PEGylated Protein Drugs: Basic Science and Clinical Applications; 2009.
   Google Scholar
• Wang F, Xu Y, Lv C, et al. Enhanced wound healing activity of PEG/PCL copolymer combined with bioactive nanoparticles in wound care after anorectal surgery: via bio-inspired methodology. J Photochem Photobiol B Biol. 2018;187:54–60.
   PubMed Web of Science ®Google Scholar
• Chang Yang G, Qin Jie W, Peng Wei D, et al. Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel. J Biomed Mater Res B. 2009;91(1):26–36.
   Google Scholar
• Chen YS, Chiu YH, Li YS, et al. Integration of PEG 400 into a self-nanoemulsifying drug delivery system improves drug loading capacity and nasal mucosa permeability and prolongs the survival of rats with malignant brain tumors. Int J Nanomed. 2019;14:3601–3613.
   PubMed Web of Science ®Google Scholar
• Chou WL, Yu DG, Yang MC, et al. Effect of molecular weight and concentration of PEG additives on morphology and permeation performance of cellulose acetate hollow fibers. Sep Purif Technol. 2007;57(2):209–219.
   Web of Science ®Google Scholar
• Amirilargani M, Mohammadi T. Effects of PEG on morphology and permeation properties of polyethersulfone membranes. Sep Sci Technol. 2009;44(16):3854–3875.
   Web of Science ®Google Scholar
• Sharifi S, Mirzadeh H, Imani M, et al. Synthesis, photocrosslinking characteristics, and biocompatibility evaluation of N-vinyl pyrrolidone/polycaprolactone fumarate biomaterials using a new proton scavenger. Polym Adv Technol. 2008;19(12):1828–1838.
   Web of Science ®Google Scholar
• Pisani S, Bruni G, Conti B, et al. Study on hydrophilicity and degradability of chitosan/polylactide-co-polycaprolactone nanofibre blend electrospun membrane. Carbohydr Polym. 2018;199:150–160.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Takebayashi Y, Otsubo T. Granule coated with urethane resin. 2010.
   Google Scholar
• Woodruff MA, Hutmacher DW. The return of a forgotten polymer—Polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217–1256.
   Web of Science ®Google Scholar
• Brzeziński M, Socka M, Makowski T, et al. Microfluidic-assisted nanoprecipitation of biodegradable nanoparticles composed of PTMC/PCL (co)polymers, tannic acid and doxorubicin for cancer treatment. Colloids Surf B. 2021;201:111598.
   PubMed Web of Science ®Google Scholar
• Damiano B, Irina M, Karl S, Johannes BM, et al. Copolymerization of caprolactone isomers to obtain nanoparticles with constant hydrophobicity and tunable crystallinity. Macromolecules. 2020;53(13):5208–5217.
   Web of Science ®Google Scholar
• Zhou Z. Study on method for quantitative analysis of trace benzene hydrocarbons by FTIR. Anal Instrum. 2010;3:42–46. (In Chinese).
   Google Scholar
• Chen H, Xu X, Gong S, et al. A comparison of ether- and alkyl-imidazolium-based ionic liquids diluted with CH3CN: a combined FTIR and DFT study. J Mol Liq. 2020;313:113542.
   Web of Science ®Google Scholar
• Pan J, Wang B, Jiang W, et al. Novel PEG-graft-PLA nanoparticles with the potential for encapsulation and controlled release of hydrophobic and hydrophilic medications in aqueous medium. Int J Nanomed. 2011;2011:1443–1451.
   Google Scholar
• Brzeziński M, Wedepohl S, Kost B, et al. M. C. Nanoparticles from supramolecular polylactides overcome drug resistance of cancer cells. Eur Polym J. 2018;109:117–123.
   Web of Science ®Google Scholar